Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationStem CellsTransplantation ConditioningAntigens, CD34Transplantation, HomologousHematopoietic Stem CellsMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisHematologic NeoplasmsCombined Modality TherapyStem Cell TransplantationBlood Component RemovalCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseMyeloablative AgonistsBusulfanGraft SurvivalTreatment OutcomeBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineCord Blood Stem Cell TransplantationCell DifferentiationHematopoiesisIfosfamideSalvage TherapyVincristineAmyloidosisCytarabineTransplantation ChimeraDisease-Free SurvivalHodgkin DiseaseTissue DonorsRetrospective StudiesNeoplasmsColony-Forming Units AssaySurvival RateBone Marrow CellsWhole-Body IrradiationTime FactorsSurvival AnalysisHistocompatibility TestingHistocompatibilityCells, CulturedInfectionLymphoma, T-CellPlatelet CountFlow CytometryDoxorubicinBlood Cell CountCell LineageTransplantation, IsogeneicPOEMS SyndromeLeukemia, Myeloid, AcuteCarboplatinPrednisoneImmunosuppressive AgentsLeukemiaDexamethasoneVidarabineRecombinant ProteinsFollow-Up StudiesCell ProliferationEmbryonic Stem CellsAntineoplastic AgentsBlood CellsBone Marrow PurgingLymphomaCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectAdult Stem CellsFatal OutcomeFeasibility StudiesImmunophenotypingMyelodysplastic SyndromesMice, Inbred C57BLMesenchymal Stem Cell TransplantationLymphocyte DepletionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticHematologic DiseasesBone MarrowT-LymphocytesCell SeparationBlood Transfusion, AutologousHLA AntigensLiver Transplantation